PTC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	833.99	984.65	779.71	594	279.83	189.72
Short-Term Investments	1,058	960.72	359.99	282.74	130.87	583.66
Cash & Short-Term Investments	1,892	1,945	1,140	876.74	410.71	773.38
Cash Growth	-6.65%	70.69%	29.99%	113.47%	-46.89%	-29.93%
Accounts Receivable	219.92	181.62	158.55	160.82	155.61	110.46
Inventory	75.57	79.65	23.19	30.58	21.81	15.86
Other Current Assets	66.05	67.31	44.09	150.49	105.66	54.68
Total Current Assets	2,254	2,274	1,366	1,219	693.79	954.37
Net Property, Plant & Equipment	129.43	135.42	117.66	178.99	175.02	130.01
Other Intangible Assets	380.68	388.75	118.79	379.5	705.89	724.84
Goodwill	82.34	82.34	82.34	82.34	82.34	82.34
Other Long-Term Assets	22.65	18.3	20.7	36.25	48.58	46.5
Total Assets	2,869	2,899	1,705	1,896	1,706	1,938
Accounts Payable	313.05	381.27	304.29	391.98	320.37	288.78
Current Portion of Long-Term Debt	286.94	286.63	-	-	-	149.54
Current Portion of Leases	18.08	15.48	13.36	16	12.37	10.27
Unearned Revenue	0.5	2.04	5.51	0.8	1.35	-
Other Current Liabilities	305.04	283	257.82	194.31	72.15	60.75
Total Current Liabilities	923.6	968.43	580.98	603.1	406.24	509.35
Long-Term Debt	-	-	285.41	284.21	571.72	281.89
Long-Term Leases	90.07	96.58	90.52	114.81	119.54	93.67
Other Long-Term Liabilities	2,036	2,039	1,846	1,712	955.21	1,052
Total Long-Term Liabilities	2,126	2,136	2,222	2,111	1,646	1,427
Total Liabilities	3,050	3,104	2,803	2,714	2,053	1,937
Common Stock	0.08	0.08	0.08	0.08	0.07	0
Additional Paid-in Capital	2,778	2,748	2,575	2,466	2,305	2,124
Accumulated Other Comprehensive Income	8.47	10.5	-25.89	-1.29	4.8	-24.28
Retained Earnings	-2,967	-2,964	-3,647	-3,284	-2,657	-2,098
Shareholders' Equity	-180.47	-205.31	-1,098	-818.56	-347.09	1.37
Total Liabilities & Equity	2,869	2,899	1,705	1,896	1,706	1,938
Total Debt	395.09	398.7	389.3	415.03	703.63	535.38
Net Cash (Debt)	1,497	1,547	750.4	461.71	-292.92	238
Net Cash Growth	-3.19%	106.11%	62.52%	-	-	-65.16%
Net Cash Per Share	18.23	17.51	9.77	6.17	-4.08	3.38
Book Value	-180.47	-205.31	-1,098	-818.56	-347.09	1.37
Book Value Per Share	-2.20	-2.32	-14.29	-10.94	-4.84	0.02
Tangible Book Value	-643.49	-676.41	-1,299	-1,280	-1,135	-805.82
Tangible Book Value Per Share	-7.84	-7.66	-16.91	-17.11	-15.83	-11.44

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q